# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-017812
Filing Date
2023-05-04
Accepted
2023-05-04 16:01:00
Documents
94
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bbio-20230331.htm iXBRL | 10-Q | 4299274
2 | EX-10.4 | bbio-ex10_4.htm | EX-10 | 131777
3 | EX-31.1 | bbio-ex31_1.htm | EX-31 | 33188
4 | EX-31.2 | bbio-ex31_2.htm | EX-31 | 33308
5 | EX-32.1 | bbio-ex32_1.htm | EX-32 | 15650
6 | EX-32.2 | bbio-ex32_2.htm | EX-32 | 15960
| Complete submission text file | 0000950170-23-017812.txt |  | 17993442

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bbio-20230331.xsd | EX-101.SCH | 124429
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bbio-20230331_lab.xml | EX-101.LAB | 861643
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bbio-20230331_def.xml | EX-101.DEF | 520618
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bbio-20230331_pre.xml | EX-101.PRE | 668581
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bbio-20230331_cal.xml | EX-101.CAL | 82764
88 | EXTRACTED XBRL INSTANCE DOCUMENT | bbio-20230331_htm.xml | XML | 3973285

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38959 | Film No.: 23888451
SIC: 2834 Pharmaceutical Preparations